What is the significance of 37 CFR 1.33 in patent applications?
37 CFR 1.33 is a crucial regulation in patent applications that governs correspondence and signature requirements. The MPEP specifically mentions this rule: Attention should be called to 37 CFR 1.33 in patent applications. This regulation is significant because it: Specifies who can sign amendments and other papers in patent applications Outlines the requirements for correspondence…
Read MoreWhat are the requirements for submitting biological sequence listings in patent applications?
The requirements for submitting biological sequence listings in patent applications depend on the filing date of the application: For applications filed before July 1, 2022: A “Sequence Listing” must be submitted as an ASCII plain text file in compliance with 37 CFR 1.821-1.824. It can be submitted via the USPTO patent electronic filing system or…
Read More